PIPERAQUINE AND RELATED DRUG COMBINATIONS FOR USE IN THE TREATMENT OF COVID-19

The present invention relates to pharmaceutical preparations / compositions comprising 4-aminoquinoline derivatives, in particular Piperaquine, Chloroquine, or Hydroxychloroquine as active ingredients, and in a further embodiment in combination with 3-N-formyl hydroxy amino propyl phosphonic acid de...

Full description

Saved in:
Bibliographic Details
Main Authors HUTCHINSON, David, LINDEMANN, Björn
Format Patent
LanguageEnglish
French
German
Published 02.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to pharmaceutical preparations / compositions comprising 4-aminoquinoline derivatives, in particular Piperaquine, Chloroquine, or Hydroxychloroquine as active ingredients, and in a further embodiment in combination with 3-N-formyl hydroxy amino propyl phosphonic acid derivatives or 3-N-acetyl hydroxy amino propyl phosphonic acid derivatives as active ingredients and optionally, in combination with an immunosuppressant for use in the prophylaxis and treatment of infections caused by RNA-viruses.
Bibliography:Application Number: EP20200192982